Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A. | Langmuir | 2022 | 36416530 | PubTator, text mining | PubMed |
| Dysregulated claudin expression significantly effect breast cancer disease progression. | J Cancer Res Ther | 2022 | 36412442 | PubTator, text mining | PubMed |
| Immunoexpression of claudin-4 and correlation with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-neu in breast cancer. | J Cancer Res Ther | 2022 | 36412441 | PubTator, text mining | PubMed |
| Pyroptosis associated with immune reconstruction failure in HIV-1- infected patients receiving antiretroviral therapy: a cross-sectional study. | BMC Infect Dis | 2022 | 36411423 | PubTator, text mining | PubMed |
| Application of extracellular vesicles proteins in cancer diagnosis. | Front Cell Dev Biol | 2022 | 36407096 | PubTator, text mining | PubMed |
| Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis. | Mol Med | 2022 | 36401163 | PubTator, text mining | PubMed |
| Chlamydia repurposes the actin-binding protein EPS8 to disassemble epithelial tight junctions and promote infection. | Cell Host Microbe | 2022 | 36395759 | PubTator, text mining | PubMed |
| Type-2 epithelial-mesenchymal transition in oral mucosal nonneoplastic diseases. | Front Immunol | 2022 | 36389753 | PubTator, text mining | PubMed |
| Selective targeting of MD2 attenuates intestinal inflammation and prevents neonatal necrotizing enterocolitis by suppressing TLR4 signaling. | Front Immunol | 2022 | 36389716 | PubTator, text mining | PubMed |
| Biological impact of restrictive and liberal fluid strategies at low and high PEEP levels on lung and distal organs in experimental acute respiratory distress syndrome. | Front Physiol | 2022 | 36388107 | PubTator, text mining | PubMed |
| Multiscale modelling of claudin-based assemblies: A magnifying glass for novel structures of biological interfaces. | Comput Struct Biotechnol J | 2022 | 36382184 | PubTator, text mining | PubMed |
| Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. | Cancer Cell Int | 2022 | 36376956 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions. | Viruses | 2022 | 36366532 | PubTator, text mining | PubMed |
| Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer. | Pharmaceutics | 2022 | 36365249 | PubTator, text mining | PubMed |
| Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut. | Nutrients | 2022 | 36364961 | PubTator, text mining | PubMed |
| The Regulation of the Hippo Pathway by Intercellular Junction Proteins. | Life (Basel) | 2022 | 36362947 | PubTator, text mining | PubMed |
| Galactomyces Ferment Filtrate Potentiates an Anti-Inflammaging System in Keratinocytes. | J Clin Med | 2022 | 36362566 | PubTator, text mining | PubMed |
| Knockdown of CLAUDIN-6 Inhibited Apoptosis and Induced Proliferation of Bovine Cumulus Cells. | Int J Mol Sci | 2022 | 36362009 | PubTator, text mining | PubMed |
| An Inflamed and Infected Reconstructed Human Epidermis to Study Atopic Dermatitis and Skin Care Ingredients. | Int J Mol Sci | 2022 | 36361668 | PubTator, text mining | PubMed |
| Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | 36358843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=36